These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11851727)

  • 21. Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.
    Puentes-Díaz N; Chaparro D; Reyes-Marquez V; Morales-Morales D; Flores-Gaspar A; Alí-Torres J
    J Alzheimers Dis; 2024; 99(s2):S383-S396. PubMed ID: 37483007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent administration of D-penicillamine and zinc has no advantages over the use of either single agent on copper excretion in the rat.
    Domingo JL; Gómez M; Jones MM
    Toxicology; 1998 Apr; 126(3):195-201. PubMed ID: 9674967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment.
    Gupte A; Mumper RJ
    Cancer Treat Rev; 2009 Feb; 35(1):32-46. PubMed ID: 18774652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of glutathione loss and nerve cell death by the transition metals iron and copper: Implications for age-related neurodegenerative diseases.
    Maher P
    Free Radic Biol Med; 2018 Feb; 115():92-104. PubMed ID: 29170091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease.
    Mota SI; Costa RO; Ferreira IL; Santana I; Caldeira GL; Padovano C; Fonseca AC; Baldeiras I; Cunha C; Letra L; Oliveira CR; Pereira CM; Rego AC
    Biochim Biophys Acta; 2015 Jul; 1852(7):1428-41. PubMed ID: 25857617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
    Robert A; Liu Y; Nguyen M; Meunier B
    Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity.
    López N; Tormo C; De Blas I; Llinares I; Alom J
    J Alzheimers Dis; 2013; 33(3):823-9. PubMed ID: 23076075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant pathways in Alzheimer's disease: possibilities of intervention.
    Viña J; Lloret A; Giraldo E; Badia MC; Alonso MD
    Curr Pharm Des; 2011 Dec; 17(35):3861-4. PubMed ID: 21933145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
    Greenough MA; Camakaris J; Bush AI
    Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.
    Deibel MA; Ehmann WD; Markesbery WR
    J Neurol Sci; 1996 Nov; 143(1-2):137-42. PubMed ID: 8981312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative Stress Markers and Metal Ions are Correlated With Cognitive Function in Alzheimer's Disease.
    Pu Z; Xu W; Lin Y; He J; Huang M
    Am J Alzheimers Dis Other Demen; 2017 Sep; 32(6):353-359. PubMed ID: 28554217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.
    Kalita J; Kumar V; Ranjan A; Misra UK
    Neuromolecular Med; 2015 Dec; 17(4):364-72. PubMed ID: 26224517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc and Copper in Alzheimer's Disease.
    Avan A; Hoogenraad TU
    J Alzheimers Dis; 2015; 46(1):89-92. PubMed ID: 25835420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats.
    Mahdy K; Shaker O; Wafay H; Nassar Y; Hassan H; Hussein A
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16 Suppl 3():31-42. PubMed ID: 22957416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
    Lannfelt L; Blennow K; Zetterberg H; Batsman S; Ames D; Harrison J; Masters CL; Targum S; Bush AI; Murdoch R; Wilson J; Ritchie CW;
    Lancet Neurol; 2008 Sep; 7(9):779-86. PubMed ID: 18672400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
    Sayre LM; Perry G; Harris PL; Liu Y; Schubert KA; Smith MA
    J Neurochem; 2000 Jan; 74(1):270-9. PubMed ID: 10617129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metal chelation as a potential therapy for Alzheimer's disease.
    Cuajungco MP; Fagét KY; Huang X; Tanzi RE; Bush AI
    Ann N Y Acad Sci; 2000; 920():292-304. PubMed ID: 11193167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment.
    Squitti R; Cassetta E; Dal Forno G; Lupoi D; Lippolis G; Pauri F; Vernieri F; Cappa A; Rossini PM
    Arch Neurol; 2004 May; 61(5):738-43. PubMed ID: 15148152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Design of Copper Ligands with Controlled Metal Chelating, Pharmacokinetics, and Redox Properties for Alzheimer's Disease.
    Chaparro D; Flores-Gaspar A; Alí-Torres J
    J Alzheimers Dis; 2021; 82(s1):S179-S193. PubMed ID: 34032611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.